Long-term stability in randomized and non-randomized patients in the phase 3 randomized, double-blind EDGE trial of once- versus twice-daily dosing of eliglustat in patients with Gaucher disease type 1

Saved in:
Bibliographic Details
Published inMolecular genetics and metabolism Vol. 123; no. 2; p. S30
Main Authors Charrow, Joel, Fraga, Cristina, Gu, Xuefan, Ida, Hiroyuki, Longo, Nicola, Lukina, Elena, Nonino, Alexandre, Gaemers, Sebastiaan J.M., Jouvin, Marie-Helene, Li, Jing, Wu, Yaoshi, Xue, Yong, Judith Peterschmitt, M.
Format Journal Article
LanguageEnglish
Published Elsevier Inc 01.02.2018
Online AccessGet full text

Cover

More Information
ISSN:1096-7192
1096-7206
DOI:10.1016/j.ymgme.2017.12.054